Latest Articles
-
Should You Buy or Sell Abbott Laboratories Stock Ahead of Its Upcoming Earnings?
Abbott Laboratories (NYSE:ABT) is set to release its second-quarter earnings on Thursday, July 17, 2025. For event-driven traders, analyzing the stock’s historical reactions to earnings reports can provide valuable insights. Looking at the...
-
Is It Time To Buy Abbott Stock Now?
Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from the company’s robust quar...
-
How Will Abbott Laboratories Stock React To Its Upcoming Earnings?
Abbott Laboratories (NYSE:ABT) is scheduled to report its earnings on Wednesday, April 16, 2025. Analysts anticipate earnings of $1.07 per share on sales of $10.41 billion for the first quarter. This represents an increase compared to the prior-y...
-
What Lies Ahead for Abbott Stock?
Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared t...
-
A Look At Abbott’s Q3 Performance
Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations . The company reported revenue of $10.64 billion and earnings of $1.21 on a per-share and adjusted basis, compared to our estimates ...
-
What To Expect From Abbott’s Q3?
Abbott (NYSE: ABT) will report its Q3 2024 results on Wednesday, Oct 16. We expect the company to post revenue of $10.6 billion and earnings of $1.20 on a per share and adjusted basis, aligning with the street expectations. We expect the compan...
-
Why Abbott Stock Looks More Attractive Than Its Medical Devices Peer
Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better pick than its peer Medtronic stock (NYSE: MDT). ABT stock trades at 4.9x trailing revenues, versus 3.6x for MDT. Although Medtronic is slightly more profitable, Abbot...
-
Should You Pick Abbott Stock At $105 After A Solid Q2?
Abbott (NYSE: ABT) recently reported its Q2 results, with revenues and earnings exceeding our expectations . The company reported revenue of $10.4 billion and earnings of $1.14 on a per-share and adjusted basis, compared to our estimates of $10...
-
Down 7% This Year Will Abbott Stock See Higher Levels Post Q2 Results?
Abbott (NYSE: ABT) will report its Q2 2024 results on Thursday, July 18. We expect the company to post revenue of $10.3 billion and earnings of $1.10 on a per share and adjusted basis, broadly aligning with the street expectations. We expect a ...
-
How Does The Current Fall In Abbott Stock Compare With The One During 2008 Recession?
Abbott stock (NYSE: ABT) currently trades at $105 per share, 25% below its peak level of over $140 seen in December 2021. In comparison, its peer Boston Scientific stock (NYSE: BSX) has seen a nearly 90% rise over this period. Abbott saw its st...
-
Should You Pick Abbott Stock At $105 After An Upbeat Q1?
Abbott (NYSE: ABT) recently reported its Q1 results, with revenues above and earnings exceeding our expectations . The company reported revenue of $10 billion and earnings of $0.98 on a per-share and adjusted basis, compared to our estimates of...
-
After Nearly A 20% Rise In Six Months Will Abbott Stock See Higher Levels Post Q1?
Abbott (NYSE: ABT) will report its Q1 2024 results on Wednesday, April 17. We expect the company to post revenue of $9.9 billion and earnings of $0.95 on a per share and adjusted basis, aligning with the street expectations. We expect a low dou...
-
What’s Next For Abbott Stock After A 6% Rise This Year?
Abbott (NYSE: ABT) reported its Q4 results last month, with revenues above and earnings aligning with the street estimates. The company reported revenue of $10.24 billion and earnings of $1.19 on a per-share and adjusted basis, compared to the ...
-
Is Abbott Stock Undervalued At $95?
Abbott (NYSE: ABT) reported its Q3 results last week, with revenues and earnings beating the street estimates. ABT stock is trading at 4.0x sales compared to the last five-year average of 5.4x, and we believe investors will likely be better off...
-
Which Is A Better Pick – Abbott Stock Or Amgen?
Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better healthcare pick than Amgen stock (NASDAQ: AMGN). Both stocks have a similar market capitalization of $150 billion to $160 billion. AMGN trades at a higher valuation m...
